GLP-1 Weight-Loss Drugs Linked to Higher Employment Rates for Women, Study Shows

Analysis of USC’s Understanding America Study shows women who began GLP-1 therapy saw a 27 % employment increase after about 18 months, versus a matched group of interested non-users. The cohort also had a similar rise in marriage or cohabitation likelihood. Life satisfaction was unchanged, and earnings could not be evaluated due to limited data.

WFLA - Tampa Bay

GLP-1 drugs are a leading pharmacological option for weight loss, producing substantial body-weight reductions. Monthly prices often exceed several hundred dollars, posing a financial barrier to broad use.

WFLA - Tampa Bay

The study used data from over 10,000 U.S. adults in the USC panel. Women who started GLP-1 therapy were compared with a control group of interested non-users, enabling assessment of employment, relationship changes, and subjective well-being.

WFLA - Tampa Bay

Harvard economist Rebecca Diamond said that large-scale pharmacological weight loss changes how society and the labor market value body weight. The federal government responded with the Medicare GLP-1 Bridge trial, providing brand-name GLP-1 drugs to eligible Medicare and Medicare Advantage beneficiaries for $50 per month, running through 2027.

WFLA - Tampa Bay

The analysis cannot confirm causal earnings effects, as income data were unavailable. Unchanged life-satisfaction scores suggest employment gains may not improve subjective well-being. High drug costs may limit the findings’ generalizability.

WFLA - Tampa Bay

• “Mass pharmacological weight loss is not only a health shock. It is also a shock to the social and labor-market valuation of body weight,” — Rebecca Diamond, Harvard University

WFLA - Tampa Bay

• “What does not change for women is equally informative. The arrangements that do not respond are the ones already in place, where any first impression occurred long ago and where weight is one characteristic embedded in a much richer stock of information.” — Rebecca Diamond, Harvard University

WFLA - Tampa Bay

• “The research paper showed that the employment rate for women who weren’t working before taking the weight loss drugs rose 27% after about a year and a half of taking GLP-1 drugs.” — Study Findings

WFLA - Tampa Bay

• “This week, the federal government began offering a selection of brand-name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called Medicare GLP-1 Bridge.” — Program Announcement

WFLA - Tampa Bay

The Medicare GLP-1 Bridge program runs until 2027, potentially expanding affordable access for older adults. Researchers plan follow-up studies to assess long-term earnings, health outcomes, and broader social effects of pharmacological weight loss.

WFLA - Tampa Bay